European equities traded in the US as American depositary receipts started the week tracking modestly higher late Monday morning, rising 0.31% to 1,970.56 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical companies argenx (ARGX) and DBV Technologies (DBVT), which climbed 16% and 5.1% respectively. They were followed by telecommunications company Nokia (NOK) and biopharmaceutical company Cellectis (CLLS), which advanced 2.5% and 2% respectively.

The decliners from continental Europe were led by medical device maker EDAP TMS (FOCL) and internet browser company Opera (OPRA), which dropped 4.6% and 2.7% respectively. They were followed by brewing company Anheuser-Busch InBev (BUD) and consumer goods company Unilever (UL), which lost 2.4% and 1.6% respectively.

The gainers from the UK were led by biotech firm Autolus Therapeutics (AUTL) and biopharmaceutical company Akari Therapeutics (AKTX), which rose 6.3% and 2.8% respectively. They were followed by biopharmaceutical companies GSK (GSK) and Bicycle Therapeutics (BCYC), which were up 1.6% and 1.5% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Mereo BioPharma Group (MREO) and communications company WPP (WPP), which fell 5.4% and 3% respectively. They were followed by alcoholic beverage company Diageo (DEO) and biopharmaceutical company NuCana (NCNA), which decreased 2.6% and 2.5% respectively.